Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Medical Devices

Medical Device Use in the Home Environment Guidance Workshop, May 24, 2010 - Breakout Session Notes: Patient Labeling

Facilitator: Pat Paterson Ageless Consulting
Scribe: Lester “Jao” Lacorte

Audience: mostly manufacturers

Facilitator requested public input in writing a guidance document on the migration of medical device technology into the home environment, specifically regarding patient labeling:

  • One size fits all model doesn’t fit
  • Less complex deices are lumped with more complex; the same regulations apply but may not be applicable/relevant
  • Some patients are computer savvy while others are not
  • Design based on therapy-driven input; requires more input from actual patient feedback
  • Homecare standards needed
  • Industry needs more patient input to customize and tailor to specific patient
  • Less-prescriptive and more user-friendly regulations needed to make it easier for industry to comply
  • Precautions, warnings and limitations
  • Labeling described as “pedantic;” labeling should be practical but should describe performance characteristics absolutely needed for manufacturers
  • Engineers and FDA have conflicting guidance in what labeling is needed for consumers
  • Consumer-based company states “unclear guidance received from FDA and engineers”
  • CDRH needs greater guidance for labeling in safety standards
  • Long vs. Short-term memory approach to product labeling and instructions
  • Operator manual different vs. Instructions that may have no table of contents
  • Too much focus relying on clinicians to train on device functions
  • Product warning and labeling
  • FDA should define “meaningful” warning labels––what should a product warning label be?
  • Customer want simple; but due to manufacturers are forced to make labels too complex due to liability issues; complex labeling and wording only discourages patient
  • Manufacturers and clinicians tend to make final decision in industry but uncertain if regulatory (FDA or company’s regulatory affairs department) makes the final decision?
  • Clinical outcomes if product already on the market; but then what data is needed to report?
  • Contradiction since everyone likes a simplified version for patient but for manufacturers, product liability is too cumbersome and complex from a legal standpoint; e.g. “manufacturers have difficulty in giving a simplified 3-page guide when a more extensive version is needed” from a legal viewpoint; IF TOO COMPLEX, PATIENTS WILL NOT READ THE MANUAL
  • Too many warnings for patient will not actually protect patient
  • “Multi-faceted approach needed”: different training instructions for patients, clinicians, Train-the-trainer for the nurses; may need to go beyond User Guide
  • “Products in the home are doing more things” compared to the institution
  • Complication of labeling in institutional vs. Homecare setting may require multi-faceted training approach
  • Same product may be used for the simple as well as complicated condition; this is a conflict in design

Facilitator question to the audience: What is special for home use care to help with adverse events, etc.?

  • Emphasized need for industry and regulators to reach out to patients
  • Devices are diverse, from the simple to the complex
  • “Where is labeling located and how is it written for them?”
  • Clinicians want one location to find labeling? Does manufacturer do this since clinicians want easier access?
    An example: Infusion pump information is needed but need to define the different components designed for each particular therapy, e.g. Intermittent or continuous setting should be defined by clinician, not manufacturer
  • Who to call when device does not work? E.g. Difficulty in engaging with product representative
  • Mary Brooks: “Lock out modes and access codes should be readily available”
  • “Instructions to trouble shoot should be the manufacturer’s issue?” vs. Regulatory
  • Clinicians also have to trouble-shoot; poses different problems
  • The three most important issues––Want a pump that is easy to use, reliable and durable,
  • How is FDA trying to integrate its standards with other agencies? Mary Brooks: “Agency is listening to all viewpoints”
  • Dilemma for industry: simple instructions at 6 grade level vs product liability with rapidly changing industry in a population that may not be tech savvy
  • Demonstration through testing of patients should be general and not specific
  • Measurable outcomes needed to make sure use is simple
  • Testing and validating label used first but human factors development process requested for manufacturers; task analysis needs to be part of development process; focus group okay buy embedded task analysis needed in product labeling
  • “Alzheimer’s patients average 75 years old with no related care givers (with) on oxygen;” difficult for Alzheimer’s patients to describe functioning of device, let alone learn
  • Family caregiver important but homecare providers who come to fix machine often becoming more important; Therefore need education for others, too
  • Instructions need to be “narrative and pictorial” (illustrated)
  • Be mindful of what manufacturers are already doing
  • “There is no simple device,” even for single use devices especially for pediatric age population; Does FDA have product labeling standards for pediatric population since pediatric actually may need to know how to use the device and have to understand instructions
  • Adult instructions different from pediatric instructions in labeling; debate on pediatric and Alzheimer’s patients and should specify how device should not be used in these populations
  • Pediatric group not indicated to get that particular therapy
  • Difficulty in writing label for each particular group involved in care vs label for actual patient
  • Combination products: Clinicians need to decide who is the appropriate user for the device
  • Consistency needed in format for labeling products since difficult to find label in the same place; need for standardization
  • Combination products: Too much information in insert will prevent patients from reading although some patients will read it thoroughly
  • Guidance requested from FDA on FONT size
  • Layman’s term required
  • Older users different from younger users; older users tend not to play and tinker with a complicated device
  • Audio instructions with online e-learning instructions; limited use of audio instructions for patient with voice guidance mode and graphics
  • Some patients may have difficult hearing and seeing
  • On-screen instructions AKA (on-screen?) Support System with a quick start guide––eliminates short/long-term memory of instructions for use
  • How much information is too much to give patients before it is a turn-off to the patient
  • Electronic support system needed
  • What things do you want manufacturers not want FDA to pursue: Give us the minimum requirements, give us objective and not be prescription
  • Electronic labeling of medical devices to download instructions from internet and voice instructions––FDA should provide guidance on this
  • Product development of manuals through acquisition and brand image; manufacturers trying to provide warnings and cautions
  • How to update older product with instructions that are not very clear––Can FDA tell us how to do that?
  • What version software is needed and how to update? Usability as to how website is designed
  • SPL labeling for devices needed, who’s responsible for updating? Is Agency responsible for this when version of instructions
  • How to update labeling without having to re-submit 510k; guidance from FDA required
  • Request FDA to have regulations on electronic labeling for home use

Q: Some patients don’t have a computer or DVD at home to view manual instructions

  • Sequential in labeling and can use hyperlinked
  • Requesting caution to use labeling instructions: not all patients search for manual information the same; NOT intuitive for older people who lose their place on websites
  • Plenty of old websites with old info; request a transitional period from FDA
  • Electronic media can make patients lost
  • Qualifications of users needed for devices; what are criteria for them to use and take device home to use?
  • Some patients may be intimidated
  • Patients given a checklist to sign to say they understand
  • Is there an FDA requirement for a checklist? ANS: NO, it is company by company
  • “Dead man’s Test,” ad dead man can pass that test
  • Pharmacists often get involved in training patients; older vs younger pharmacists e.g. Younger pharmacist didn’t realize patient is hard of hearing
  • Demos needed
  • What do you FDA’s labeling guidance to have?: Manufacturer designs instructions and a 3rd party can validate
  • How do you customize instructions for home infusion nurse vs the patient
  • There are good and poor trainers
  • Multiple sources of training is required
  • New 510k shouldn’t have to be needed
  • Customer support and feedback from supplier; report loop to get feedback on how labeling is produced
  • Is there anything Pat Paterson said that didn’t make sense?
  • Type of device may be a really simple device being lumped in with more complex devices is of concern in guidance document e.g. No electronic interface is needed; suggest 2 different requirements may be necessary

Page Last Updated: 04/15/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English